BioSpace News Archive

Australian and Japanese grants bring owned patents to nine

Annual industry survey predicts what you’ll see in fitness next year

Findings provide hope for long-term survival for HER2+ breast cancer patients

The modern workplace has undergone a transformation as workers move away from traditional industrial sectors, such as agriculture and manufacturing, into the service sector.

Independent Data Monitoring Committee responsible for ongoing review of study data recommended enrollment be stopped

Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced that Scientific Advisory Board Member, Donald B. Kohn, MD, presented clinical proof-of-concept data from an ongoing academic clinical trial evaluating OTL-102 for the treatment of X-Linked Chronic Granulomatous Disease

Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentations.

Medicenna Therapeutics Corp. announced today that it has received US$1,224,540 (approximately, CD$1.6M) from the Cancer Prevention and Research Institute of Texas (“CPRIT”).

contextflow, a recognized name in the highly competitive field of AI in medical image processing, is one of only 19 startups from 14 countries invited to participate in a 12-week “AI in Healthcare” startup-accelerator program spearheaded by Philips HealthWorks, a global leader in health technology

Presenters to Speak on Best Practices, Implementation Strategies, and Recommendations on Meeting State Regulations